NAYZILAM vs ONFI

Independent side-by-side comparison.

Rated against independent regulatory sources·Last updated October 9, 2026·How we rate

Possible drug interaction. NAYZILAM and ONFI are different prescription medicines. Combining or switching between them can cause interactions — talk to a pharmacist or prescriber before making changes. This page is not medical advice.

Attribute	NAYZILAM	ONFI
Rating	70/100	70/100
Pharmacy pays	$0.45 /mL	~$7.42 /30
Type	RX	RX
Active ingredient	MIDAZOLAM	CLOBAZAM
Manufacturer	Ucb Inc	Lundbeck Pharms LLC
Dosage forms	Spray/Inhaler	Suspension, Tablet
Drug class	Benzodiazepine	Benzodiazepine
Boxed warning	Boxed warning	Boxed warning
Treats	Anxiety Disorders, Psychomotor Agitation, Status Epilepticus	Seizures, Lennox Gastaut Syndrome

nayzilam onfi

Rating

70/100

Pharmacy pays

$0.45 /mL

~$7.42 /30

Type

Active ingredient

MIDAZOLAM

CLOBAZAM

Manufacturer

Ucb Inc

Lundbeck Pharms LLC

Dosage forms

Spray/Inhaler

Suspension, Tablet

Drug class

Benzodiazepine

Boxed warning

Treats

Anxiety Disorders, Psychomotor Agitation, Status Epilepticus

Seizures, Lennox Gastaut Syndrome

Frequently asked questions

Which is better-rated, Nayzilam or Onfi?

Nayzilam and Onfi are tied at 3.5 out of 5 by our independent rating.

What is the difference between Nayzilam and Onfi?

Nayzilam contains Midazolam, while Onfi contains Clobazam — they have different active ingredients.

Ratings are based on FDA regulatory (recall-safety) data. This comparison is for general reference only — not medical advice. Always consult a licensed professional before choosing or switching a medication.